Kentaro Suzuki
CIK: 0002037191
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nautilus Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026NAUT
Nautilus Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
160K shares- - Nov 6, 2025NAUT
Nautilus Biotechnology, Inc.
Purchase(P)Direct4K shares at avg. $1.49$6K - Mar 3, 2025NAUT
Nautilus Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
50K shares- - Sep 16, 2024NAUT
Nautilus Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
375K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | NAUT Nautilus Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 160,000 | - | - | Direct |
| Nov 6, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase(P) | 4,000 | $1.49 | $5,960 | Direct |
| Mar 3, 2025 | NAUT Nautilus Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Sep 16, 2024 | NAUT Nautilus Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 375,000 | - | - | Direct |
1-4 of 4 transactions
About Suzuki Kentaro
Suzuki Kentaro (SEC CIK 0002037191) files insider reports with the SEC as Chief Marketing Officer of Nautilus Biotechnology, Inc. (NAUT).
Signal8 holds 5 ownership filings by Suzuki Kentaro (1 Form 3, 4 Form 4), filed between Sep 17, 2024 and Mar 4, 2026. Those filings report 4 transactions, from Sep 16, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Suzuki Kentaro's filings is in SEATTLE, WA.
Recent filings by Suzuki Kentaro
Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)
- Posard Matthew L., Director
- NAZEM FARZAD, Director
- Akinsanya Karen, Director
- McIlwain Matthew S, Director
- Epperly Melissa B,, Director
- AH Equity Partners Bio II, L.L.C., 10% Owner